08/28/2024
3:05 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:47 PM | Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/26/2024
3:21 PM | Eli Lilly and Company (Issuer)
Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/22/2024
11:54 AM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
3:12 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:14 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:15 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
08/20/2024
3:17 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/20/2024
3:18 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/16/2024
7:51 AM | Eli Lilly and Company (Filed by)
Morphic Holding, Inc. (Subject)
| Form SC TO-T/A | |
08/14/2024
11:27 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/13/2024
3:31 PM | Eli Lilly and Company (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
08/13/2024
3:19 PM | Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/12/2024
3:51 PM | Eli Lilly and Company (Subject)
| Form FWP | |
08/12/2024
7:12 AM | Eli Lilly and Company (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
08/08/2024
10:28 AM | Eli Lilly and Company (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:04 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
5:07 AM | Eli Lilly and Company (Filed by)
Morphic Holding, Inc. (Subject)
| Form SC TO-T/A | |
07/19/2024
3:16 PM | Brooks Gordon J. (Reporting)
Eli Lilly and Company (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/19/2024
5:09 AM | Eli Lilly and Company (Filed by)
Morphic Holding, Inc. (Subject)
| Form SC TO-T | |
07/16/2024
3:17 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:18 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:20 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:21 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/16/2024
3:22 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
12:19 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/10/2024
7:40 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/09/2024
3:00 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
6:14 AM | Eli Lilly and Company (Filed by)
Morphic Holding, Inc. (Subject)
| Form SC TO-C | |
07/02/2024
3:00 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/28/2024
1:25 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/26/2024
3:00 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2024
1:43 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/18/2024
3:22 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:23 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/14/2024
1:49 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
1:03 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
1:23 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2024
6:48 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/04/2024
3:14 PM | Eli Lilly and Company (Issuer)
Rau Diogo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
5:29 PM | Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Biden’s Capital Gains Tax to Devastate Savings! (Ad) Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial independence and security. >> Get Your FREE Wealth Protection Guide << |
06/03/2024
5:30 PM | Eli Lilly and Company (Subject)
Norton Johna (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
3:14 PM | Eli Lilly and Company (Issuer)
Norton Johna (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/31/2024
1:32 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
2:13 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/21/2024
3:18 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
3:19 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
2:20 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/30/2024
11:04 AM | Eli Lilly and Company (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/30/2024
6:04 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/16/2024
3:11 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:12 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:13 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:14 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/11/2024
11:59 AM | AS YOU SOW (Filed by)
Eli Lilly and Company (Subject)
| Form PX14A6G | |
03/28/2024
12:10 PM | Chevedden John (Filed by)
Eli Lilly and Company (Subject)
| Form PX14A6G | |
03/28/2024
11:20 AM | Eli Lilly and Company (Subject)
Trinity Health Corp (Filed by)
| Form PX14A6G | |
03/11/2024
3:24 PM | Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/21/2024
3:26 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:16 PM | Alvarez Ralph (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
3:18 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2024
10:44 AM | Eli Lilly and Company (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/15/2024
2:05 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/14/2024
3:43 PM | Dozier Eric (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:44 PM | Eli Lilly and Company (Issuer)
White Anne E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:34 PM | Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:36 PM | Eli Lilly and Company (Issuer)
Skovronsky Daniel (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:23 PM | Eli Lilly and Company (Issuer)
Rau Diogo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
3:25 PM | Eli Lilly and Company (Issuer)
Jonsson Patrik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/09/2024
10:56 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/09/2024
8:26 AM | Eli Lilly and Company (Subject)
PNC FINANCIAL SERVICES GROUP, INC. (Filed by)
| Form SC 13G/A | |
02/08/2024
2:34 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
02/07/2024
4:08 PM | Eli Lilly and Company (Subject)
| Form FWP | |
02/07/2024
7:12 AM | Eli Lilly and Company (Filer)
| Form 424B2
Transaction specifc information for a delayed shelf offering | |
02/06/2024
6:04 AM | Eli Lilly and Company (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
3:32 PM | Eli Lilly and Company (Issuer)
Hakim Anat (Reporting)
Hakim Anat (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/02/2024
3:20 PM | Eli Lilly and Company (Issuer)
White Anne E. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
2:26 PM | BlackRock Inc. (Filed by)
Eli Lilly and Company (Subject)
| Form SC 13G/A | |
01/17/2024
3:15 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:17 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/17/2024
3:19 PM | Eli Lilly and Company (Issuer)
Sulzberger Gabrielle (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/16/2024
2:22 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
01/12/2024
3:05 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/05/2024
1:15 PM | Eli Lilly and Company (Issuer)
LILLY ENDOWMENT INC (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
2:11 PM | Eli Lilly and Company (Subject)
LILLY ENDOWMENT INC (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023
5:40 PM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
12/18/2023
5:59 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
12/04/2023
3:17 PM | Eli Lilly and Company (Issuer)
Zakrowski Donald A (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/04/2023
6:04 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/21/2023
3:27 PM | Eli Lilly and Company (Issuer)
LUCIANO JUAN R (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:29 PM | Eli Lilly and Company (Issuer)
Runge Marschall S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad) WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock
This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race… Click here to see a unique election-year trade |
11/21/2023
3:15 PM | Baicker Katherine (Reporting)
Eli Lilly and Company (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:18 PM | Eli Lilly and Company (Issuer)
Fyrwald J Erik (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:20 PM | Eli Lilly and Company (Issuer)
Hedley Mary Lynne (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:22 PM | Eli Lilly and Company (Issuer)
JACKSON JAMERE (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
3:24 PM | Eli Lilly and Company (Issuer)
JOHNSON KIMBERLY H (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/17/2023
5:53 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/15/2023
5:51 AM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/08/2023
4:06 PM | Eli Lilly and Company (Filed by)
POINT Biopharma Global Inc. (Subject)
| Form SC TO-T/A | |
11/06/2023
5:09 PM | Eli Lilly and Company (Subject)
Zakrowski Donald A (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free LLY Stock Alerts